.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Effective **epilepsy self-management** is essential for patients facing chronic neurological challenges. However, while medication remains the foundation of treatment, behavioral interventions significantly improve overall outcomes. Consequently, a recent randomized controlled trial evaluated the SMART program, an evidence-based self-management initiative. This study specifically aimed to identify which psychological factors drive the improvement in management skills. Furthermore, the trial included 160 individuals with epilepsy who were randomized to either the SMART intervention or standard care. Notably, researchers measured several potential mediators at baseline, 13 weeks, and six months. These included depressive symptom severity, self-efficacy, and perceived stigma. Additionally, multivariable linear regression models estimated the average causal mediation effect. Therefore, this approach allowed the team to identify the primary success drivers within the program.
Resultantly, the study revealed that reducing depressive symptoms was the most powerful driver of success. Specifically, mood improvements from baseline to six months accounted for 23.2% of the total treatment effect. Moreover, this finding underscores the bidirectional relationship between mental health and epilepsy. Therefore, clinicians should prioritize screening for and managing depression as part of comprehensive epilepsy care. In addition, increases in self-efficacy played a significant role. Interestingly, this factor refers to a patient\'s belief in their ability to manage their health effectively. The researchers found that improvements in self-efficacy accounted for 4.6% of the overall benefit. However, perceived stigma did not significantly mediate the association between the intervention and self-management skills. Consequently, researchers suggest that stigma reduction may not be the primary mechanism for this specific program.
Ultimately, these findings have significant implications for clinical practice in India. Similarly, because studies show that up to 48% of Indian patients with epilepsy may experience depression, integrated programs are critical. Thus, by targeting both mood and self-belief, healthcare providers can empower patients to take control of their health journeys. Therefore, these targeted strategies help reduce negative health events and improve long-term outcomes. As a result, the integration of mental health support into routine care can transform the management of epilepsy in a primary care setting.
SMART stands for Self-management for people with epilepsy and a History of Negative Health Events. It is a structured, group-format program designed to help patients manage seizures and related complications through education and peer support.
Depression is a common comorbidity that often hinders a patient\'s ability to adhere to treatment or manage seizure triggers. Improving mood directly enhances a patient\'s capacity to perform the daily tasks required for effective management.
Self-efficacy boosts a patient\'s confidence in their ability to handle their condition. When patients believe they can manage their symptoms, they are more likely to adopt healthy behaviors and respond proactively to health challenges.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References
Armah L et al. Mediating effects of depression, stigma, and self-efficacy on self-management improvement in an evidence-based epilepsy self-management program. Epilepsy Behav. 2026 May 22. doi: undefined. PMID: 42172702.
Sriramakrishnan V, Stany AI, Karunaharan V. Prevalence of Depression in Patients with Epilepsy: A Single Center Cross-sectional Study at a Tertiary Care Hospital. J Assoc Physicians India 2024;72(11):e12-e15.
Sajatovic M et al. Self-management for people with epilepsy and a history of negative health events (SMART): A randomized controlled effectiveness trial. Epilepsy Behav. 2025;110495.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A randomized trial highlights how reducing depression and increasing self-efficacy are key drivers for improving epilepsy self-management via the SMART prog...
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
